Total Funding
38
79
Total FundingVenture - Series Unknown raised
Growth Score
-3 pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
74767
MVRx is a medical device company that introduces ARTO System, a transcatheter annular reduction therapy.
Samantha Greene: Chief Executive Officer
About the Company
MVRx is a medical device company that introduces ARTO System, a transcatheter annular reduction therapy.
The ARTO System is a unique endovascular therapy for mitral valve regurgitation associated with congestive heart failure. The system treats heart failure by reducing the backward leakage of blood through the mitral valve thereby increasing the
forward flow of blood to the rest of the body. ARTO directly reshapes the mitral annulus and improves leaflet coaptation by shortening the minor axis of the mitral valve through inward displacement of the septal and lateral walls. This reestablishes normal anatomic relationships and decreases regurgitation.
